nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—AGTR1—blood plasma—bipolar disorder	0.099	0.264	CbGeAlD
Eprosartan—CYP2C9—urine—bipolar disorder	0.0914	0.243	CbGeAlD
Eprosartan—AGTR1—adrenal cortex—bipolar disorder	0.0503	0.134	CbGeAlD
Eprosartan—CYP2C9—blood plasma—bipolar disorder	0.0477	0.127	CbGeAlD
Eprosartan—AGTR1—thyroid gland—bipolar disorder	0.035	0.0933	CbGeAlD
Eprosartan—AGTR1—nervous system—bipolar disorder	0.0295	0.0785	CbGeAlD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.029	0.0465	CbGpPWpGaD
Eprosartan—AGTR1—brain—bipolar disorder	0.0225	0.06	CbGeAlD
Eprosartan—AGTR1—Peptide GPCRs—TACR1—bipolar disorder	0.0221	0.0354	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—DGKH—bipolar disorder	0.0163	0.0262	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-E—bipolar disorder	0.0155	0.0249	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.0146	0.0234	CbGpPWpGaD
Eprosartan—AGTR1—Arf6 trafficking events—INS—bipolar disorder	0.0124	0.0198	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.0116	0.0185	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC5A3—bipolar disorder	0.0114	0.0182	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.0113	0.0181	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—TACR1—bipolar disorder	0.0105	0.0169	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—TACR1—bipolar disorder	0.0104	0.0167	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.0101	0.0162	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.0099	0.0159	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00942	0.0151	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00859	0.0137	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—TAC1—bipolar disorder	0.00848	0.0136	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00842	0.0135	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00768	0.0123	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD5—bipolar disorder	0.00754	0.0121	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SERPINA1—bipolar disorder	0.00754	0.0121	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00753	0.0121	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00698	0.0112	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00698	0.0112	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00674	0.0108	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00651	0.0104	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00651	0.0104	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A4—bipolar disorder	0.00641	0.0103	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TRPM2—bipolar disorder	0.00634	0.0102	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00631	0.0101	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00612	0.0098	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL1B—bipolar disorder	0.0061	0.00977	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00578	0.00925	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SLC6A3—bipolar disorder	0.00571	0.00914	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.0057	0.00913	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00569	0.00911	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00558	0.00893	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00558	0.00893	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—ADM—bipolar disorder	0.00545	0.00873	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.0054	0.00865	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—TSHB—bipolar disorder	0.00531	0.00851	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—TACR1—bipolar disorder	0.00531	0.00851	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00524	0.0084	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00517	0.00827	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00514	0.00822	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00489	0.00782	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DGKH—bipolar disorder	0.00466	0.00746	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00462	0.0074	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR1A—bipolar disorder	0.0044	0.00704	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—NRG1—bipolar disorder	0.00436	0.00698	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—TAC1—bipolar disorder	0.00433	0.00693	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD5—bipolar disorder	0.00426	0.00682	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2C—bipolar disorder	0.00425	0.0068	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD1—bipolar disorder	0.00425	0.0068	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DGKH—bipolar disorder	0.00423	0.00677	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RGS4—bipolar disorder	0.00418	0.00669	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD3—bipolar disorder	0.00411	0.00659	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—POMC—bipolar disorder	0.00407	0.00652	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00399	0.00639	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD4—bipolar disorder	0.00399	0.00639	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD5—bipolar disorder	0.00387	0.0062	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RGS4—bipolar disorder	0.0038	0.00608	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—DRD2—bipolar disorder	0.00372	0.00596	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.00364	0.00583	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.0035	0.0056	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00342	0.00548	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00323	0.00517	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADM—bipolar disorder	0.00308	0.00493	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TSHB—bipolar disorder	0.003	0.00481	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TACR1—bipolar disorder	0.003	0.00481	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PDE4B—bipolar disorder	0.003	0.00481	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TRPC3—bipolar disorder	0.00293	0.0047	CbGpPWpGaD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.00281	0.0045	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADM—bipolar disorder	0.0028	0.00448	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.00276	0.00442	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00273	0.00437	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TSHB—bipolar disorder	0.00273	0.00436	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PDE4B—bipolar disorder	0.00273	0.00436	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TACR1—bipolar disorder	0.00273	0.00436	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKR1C4—bipolar disorder	0.00272	0.00435	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HTR2A—bipolar disorder	0.00261	0.00417	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DGKH—bipolar disorder	0.0025	0.004	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00249	0.00398	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—TAC1—bipolar disorder	0.00245	0.00392	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD1—bipolar disorder	0.0024	0.00384	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2C—bipolar disorder	0.0024	0.00384	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD3—bipolar disorder	0.00232	0.00372	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD5—bipolar disorder	0.00229	0.00366	CbGpPWpGaD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.00228	0.00365	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1A—bipolar disorder	0.00226	0.00361	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD4—bipolar disorder	0.00226	0.00361	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RGS4—bipolar disorder	0.00224	0.00359	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—TAC1—bipolar disorder	0.00222	0.00356	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2C—bipolar disorder	0.00218	0.00349	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD1—bipolar disorder	0.00218	0.00349	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADCY2—bipolar disorder	0.00212	0.0034	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD3—bipolar disorder	0.00211	0.00338	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—DRD2—bipolar disorder	0.0021	0.00337	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—POMC—bipolar disorder	0.00208	0.00333	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD4—bipolar disorder	0.00205	0.00328	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.002	0.0032	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADCY2—bipolar disorder	0.00193	0.00309	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—DRD2—bipolar disorder	0.00191	0.00306	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—COMT—bipolar disorder	0.00187	0.003	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—MAOA—bipolar disorder	0.00186	0.00297	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	0.00185	0.00295	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.00183	0.00293	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.00182	0.00291	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.0018	0.00288	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TRPC3—bipolar disorder	0.00173	0.00277	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADM—bipolar disorder	0.00165	0.00265	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TSHB—bipolar disorder	0.00161	0.00258	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PDE4B—bipolar disorder	0.00161	0.00258	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TACR1—bipolar disorder	0.00161	0.00258	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—IMPA2—bipolar disorder	0.0016	0.00256	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR2A—bipolar disorder	0.00147	0.00236	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—bipolar disorder	0.00134	0.00214	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1A—bipolar disorder	0.00133	0.00213	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TAC1—bipolar disorder	0.00131	0.0021	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD1—bipolar disorder	0.00129	0.00206	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2C—bipolar disorder	0.00129	0.00206	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK2—bipolar disorder	0.00125	0.00201	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD3—bipolar disorder	0.00125	0.002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GSK3A—bipolar disorder	0.00124	0.00199	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.00122	0.00195	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD4—bipolar disorder	0.00121	0.00194	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—bipolar disorder	0.00121	0.00194	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—bipolar disorder	0.00118	0.00188	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADCY2—bipolar disorder	0.00114	0.00182	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TCF7L2—bipolar disorder	0.00114	0.00182	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DRD2—bipolar disorder	0.00113	0.00181	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.00108	0.00173	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—bipolar disorder	0.00107	0.00171	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.00106	0.00169	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NTRK1—bipolar disorder	0.00102	0.00163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—S100B—bipolar disorder	0.000993	0.00159	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.00092	0.00147	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.000891	0.00143	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NRG1—bipolar disorder	0.000876	0.0014	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.0008	0.00128	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—bipolar disorder	0.00079	0.00126	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NCAN—bipolar disorder	0.000765	0.00122	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.00075	0.0012	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GSK3B—bipolar disorder	0.000636	0.00102	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—bipolar disorder	0.000631	0.00101	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—INS—bipolar disorder	0.000627	0.001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CLOCK—bipolar disorder	0.000542	0.000868	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TPH2—bipolar disorder	0.000528	0.000845	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TSHB—bipolar disorder	0.000528	0.000845	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNB2—bipolar disorder	0.000528	0.000845	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DPYD—bipolar disorder	0.00052	0.000832	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CACNA1C—bipolar disorder	0.000483	0.000773	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	0.000471	0.000754	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	0.000464	0.000744	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SNAP25—bipolar disorder	0.000422	0.000676	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ADCY2—bipolar disorder	0.000374	0.000598	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COMT—bipolar disorder	0.00032	0.000512	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MAOA—bipolar disorder	0.000318	0.000509	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—bipolar disorder	0.000259	0.000414	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—bipolar disorder	0.000207	0.000331	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—INS—bipolar disorder	0.000206	0.000329	CbGpPWpGaD
